Ingen Passes ISO Audit and Completes DAPA Application

/ Source: GlobeNewswire

YUCAIPA, Calif., March 15, 2011 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), an ISO 13485:2003 certified medical device manufacturer of respiratory medical devices confirms recent compliance with ISO certification.

On February 15, 2011, BSI America performed the company's six month ISO Continuing Assessment (Surveillance) audit to verify that Ingen Technologies continues to implement all the elements of the scope of registration and the requirements of ISO 13485:2003, Part 1 of the Canadian Medical Device Regulations, and MDD 93/42/EEC Annex V 3.2 which are incorporated in the organization's management system. Other documents used throughout the audit include GD210, BSI "Conditions of Contract" for the 13485:2003 certifications. On February 25, 2011 BSI America submitted the results of the assessment which verify that Ingen Technologies' capability to systematically meet agreed requirements for products and services supplied within the scope of the certificate is confirmed, and Ingen Technologies meets the applicable requirements of the ISO 13485:2003, part 1 of CMDR, and of the MDD 93/42/EEC, Annex V (M5). The company management has completed the review of this document and released this information today. ISO certification allows the company to sell its products internationally.

Further, the company completed the final documents and negotiations with both the General Services Administration (GSA) on February 22, 2011 and the Defense Acquisition Program Administration (DAPA) on March 10, 2011 in order to pursue government hospital and military sales of our products. Both of these organizations will inform the company of the status and possible contract award details in the next 30 days.

"In our drive to become a leading, innovative and commercially successful medical device manufacturing company, dedicated to improving health and quality-of-life with novel respiratory products for the hundreds of millions of Chronic Obstructive Pulmonary Disease ("COPD") sufferers worldwide, and other serious respiratory diseases, we are focused on export and international distribution of our Smart Nasal Cannula and Oxyview flow meter. Our products continue to receive tremendous support from the professional community to include the COPD Foundation, Alpha-1 Foundation, Emphysema Foundation (EFFORTS), National Home Oxygen Patient Association, American Academy of Respiratory Therapy and many other professional organizations," stated Gary Tilden, Chairman of the Board.

About Ingen:

Our wholly owned subsidiary is an established ISO certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the US, and $8 billion globally. Visit .

The Ingen Technologies, Inc. logo is available at

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

CONTACT: Gary Tilden, Chairman 909-790-7180 www.INGEN-TECH.COM